Citation Impact
Citing Papers
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
2008
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non–Small-Cell Lung Cancer
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
2010
Cancer statistics, 2017
2017 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies
2011
Pancreatic cancer
2004 Standout
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
2014
Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study
2019
Pancreatic cancer
2020 Standout
Cancer statistics, 2013
2013 Standout
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
2009
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
2014
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Lung Cancer
2008 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents
2008
Pancreatic cancer
2016 Standout
Mechanisms of resistance to antiangiogenesis therapy
2010
An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
2011
Lung cancer: current therapies and new targeted treatments
2016 Standout
Combined autophagy and proteasome inhibition
2014
Global cancer statistics
2011 Standout
Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation
2008
Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy
2011
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
2016
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Cancer statistics, 2012
2012 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Malignant Gliomas in Adults
2008 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer
2019
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
2008
Microenvironmental regulation of metastasis
2008 Standout
Targeting autophagy in cancer
2017 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Clinical targeting of the TNF and TNFR superfamilies
2013
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity
2014
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
2013
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
2008
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Cancer Statistics, 2010
2010 Standout
Pancreatic cancer
2011 Standout
Detection of Early-Stage Pancreatic Adenocarcinoma
2010
Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor
2008
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
2008
Treatment of locally advanced pancreatic cancer with irreversible electroporation – a Danish single center study of safety and feasibility
2019
Combination therapy in combating cancer
2017 Standout
Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan
2018
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer
2008
Cancer statistics, 2014
2014 Standout
Irreversible Electroporation in Hepatopancreaticobiliary Tumours
2018
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
2012
Global cancer statistics, 2012
2015 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Works of Caio Rocha‐Lima being referenced
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
2012
Role of Combined-Modality Therapy in the Management of Locally Advanced Rectal Cancer
2008
Is Adjuvant 5-FU–Based Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma Beneficial? A Meta-analysis of an Unanswered Question
2006
Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer
2005
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
2012
Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma
2016
New Therapeutic Directions for Advanced Pancreatic Cancer: Targeting the Epidermal Growth Factor and Vascular Endothelial Growth Factor Pathways
2008
Multicenter study of radiosensitizing gemcitabine combined with fractionated radioimmunotherapy for repeated treatment cycles in advanced pancreatic cancer
2009
Bortezomib With or Without Irinotecan in Relapsed or Refractory Colorectal Cancer: Results From a Randomized Phase II Study
2008
EGFR Targeting of Solid Tumors
2007
Combining glycolytic inhibitors with chemotherapy: Phase I trial of 2-deoxyglucose and docetaxel in patients with solid tumors
2005
A phase I study of brivanib alaninate (BMS-582664), an oral dual inhibitor of VEGFR and FGFR tyrosine kinases, in combination with full dose cetuximab (BC) in patients (pts) with advanced gastrointestinal malignancies (AGM) who failed prior therapy
2008